Broadfoot Jill Marie
SEC insider (Form 3/4/5 filer). CIK 0001305178. Director at TALPHERA, INC. (TLPH) and 2 other issuers. 10 reported Form 4/5 transactions since Sep 2024; latest on Jun 22, 2026. Located in SAN MATEO, CA.
Companies Broadfoot Jill Marie has filed insider reports for
- TALPHERA, INC. (TLPH): Director
- aTYR PHARMA INC (ATYR): Officer, Chief Financial Officer
- Cue Biopharma, Inc. (CUE): Director
Broadfoot Jill Marie
CIK: 0001305178
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (10 total)
- Jun 22, 2026TLPH
TALPHERA, INC.
AwardDirect5.1K shares- - Feb 4, 2026ATYR
aTYR PHARMA INC
SaleDirect1.6K shares at avg. $0.98$2K - Feb 3, 2026ATYR
aTYR PHARMA INC
ExerciseDirect3.8K shares- - Jan 9, 2026ATYR
aTYR PHARMA INC
AwardDirectEmployee Stock Option (right to buy)
412.5K shares- - Jan 2, 2026CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
24.4K shares- - Oct 23, 2025TLPH
TALPHERA, INC.
AwardDirect4.3K shares- - Jun 4, 2025CUE
Cue Biopharma, Inc.
AwardDirectStock Option (right to buy)
48.8K shares- - Feb 4, 2025ATYR
aTYR PHARMA INC
SaleDirect1.3K shares at avg. $3.78$5K - Feb 3, 2025ATYR
aTYR PHARMA INC
ExerciseDirect3.8K shares- - Jan 8, 2025ATYR
aTYR PHARMA INC
AwardDirectEmployee Stock Option (right to buy)
275K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 22, 2026 |  TLPH TALPHERA, INC. | Award | 5,100 | - | $0 | Direct |
| Feb 4, 2026 |  ATYR aTYR PHARMA INC | Sale | 1,558 | $0.98 | $1,521 | Direct |
| Feb 3, 2026 | ATYR aTYR PHARMA INC | Exercise | 3,750 | - | $0 | Direct |
| Jan 9, 2026 | ATYR aTYR PHARMA INC | Award Employee Stock Option (right to buy) | 412,500 | - | - | Direct |
| Jan 2, 2026 |  CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 24,400 | - | - | Direct |
| Oct 23, 2025 | TLPH TALPHERA, INC. | Award | 4,267 | - | - | Direct |
| Jun 4, 2025 | CUE Cue Biopharma, Inc. | Award Stock Option (right to buy) | 48,800 | - | - | Direct |
| Feb 4, 2025 | ATYR aTYR PHARMA INC | Sale | 1,254 | $3.78 | $4,740 | Direct |
| Feb 3, 2025 | ATYR aTYR PHARMA INC | Exercise | 3,750 | - | - | Direct |
| Jan 8, 2025 | ATYR aTYR PHARMA INC | Award Employee Stock Option (right to buy) | 275,000 | - | - | Direct |
1-10 of 10 transactions